"...you cannot say that the MBT trials are a flop and could never make it to commercialization ( now your going to tell me technically you have not said this). Don't mix up a change in strategy , with Scientific efficacy or not"
You are right, I am going to tell you that I did not say the trials are a flop.
In fact, what I was exactly saying related to the "change in strategy", specifically, how something that was close to revenue generation at one point in time could subsequently all but disappear from the radar... until 5 years later when a change of strategy is announced.
Maybe its just me, but I would have thought that when you have a product that is close to commercialisation, no matter how modest the revenue opportunity is perceived to be, and you are not short of cash (MSB had almost $300m in the bank at the time), then you get that product launched.
Because once you have one product in the market, then that would provide significant validation over the rest of your product suite under development.
At least, that's what the "multiple shots on goal" strategy (remember that one?) was all about, I clearly recall.
Finally - my sincere appreciation to the Hotman for unashamedly having the decency of confirming he is a shorter. It would be appropriate if others did the same (excluding Atiske). It doesn't change anything , just a little bit of decency on the forum. "
What if @aatisket is really, truly and honestly not a shorter, and therefore there is nothing for him/her to confirm? Does that still constitute a lack of decency on his/her part?
MSB Price at posting:
$1.28 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)